Current Position, Affiliation
- Division of Nephrology, Department of Internal Medicine, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
- School of Medicine, Fu-Jen Catholic University, New Taipei, Taiwan
Education / Training
- 2006, M.D., The Degree of Doctor of Medicine in Kaohsiung Medical University
- 2020, PhD., Doctor of Philosophy, Institute of Clinical Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan
Professional and Research Experience
- 2019 - Present, Chief, Dialysis Access Management Center, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
- 2025 - Present, Chief, Sheng Hsien Hemodialysis Ward, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
- 2014 - , Attending physician, Division of Nephrology, Department of Internal Medicine, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
- 2025 - , Associate Professor, Department of Medicine, Fu-Jen Catholic University
- 2021 - 2025, Assistant Professor, Department of Medicine, Fu-Jen Catholic University
Awards & Honors
- 2022, Excellent Paper Award and Outstanding Research Award, Shin Kong Hospital
- 2022, SNQ National Quality Mark Certification, Medical Affairs Council
- 2023-2024, Ministry of Science and Technology Kidney and Urology Research Program Grant
- 2024, Physician Paper Award and Outstanding Research Award, Shin Kong Hospital
- 2025, Republic of China Patent Certificate (Invention No. I885336)
Selected Publications
- Renal tubular epithelial TRPA1 acts as an oxidative stress sensor to mediate ischemia-reperfusion-induced kidney injury through MAPKs/NF-κB signaling. International Journal of Molecular Science
- Association of aortic arch and aortic valve calcifications with cardiovascular risk in patients on maintenance hemodialysis.
- Long-term effectiveness of cilostazol in patients with hemodialysis with peripheral artery disease.
- A collaborative model between dialysis clinics and a hospital center improves the quality of vascular access care and intervention for hemodialysis patients.
- Aortic arch calcification increases major adverse cardiac event risk, modifiable by echocardiographic left ventricular hypertrophy, in end-stage kidney disease patients.
Building Resilience in Hemodialysis Access: Advances in Treatment and Care
Role
Speaker
Date & Time
12/06 16:25 - 16:40
Place
Room 5 ( 701G )
Lecture Title
Integrated Care of Hemodialysis Vascular Access: From Maze to Mastery